Top Journalists
>
Michelle Llamas

Michelle Llamas

Senior Writer and Board Certified Patient Advocate at Drugwatch

Contact this person
Email address
m*****@*******.comGet email address
Influence score
46
Location
United States
Languages
  • English
Covering topics
  • Commerce
  • General Assignment News
  • Health & Medicine

View more media outlets and journalists by signing up to AI PR

View latest data and reach out all from one place
Sign up to AI PR Toolkit

Recent Articles

drugwatch.com

After 10 Years, the FDA Is Still Letting Women Down

In 2015, DrugWatch reported how oversight and shortcuts at the FDA put women at risk. After 10 years, we follow up on what’s improved and where medical device and drug gaps still leave women vulnerable.
drugwatch.com

Dupixent Lawsuit and Settlement Information: T-Cell Lymphoma

Studies link Dupixent to cutaneous T-cell lymphoma (CTCL), a rare cancer that affects the skin. Learn about lawsuits and see if you qualify to file a case.
drugwatch.com

Ozempic NAION Lawsuits: Q&A With Attorney Trent Miracle

Attorney Trent Miracle discusses why people are filing GLP-1 drug NAION vision loss lawsuits and how to file a claim.
drugwatch.com

Washington Woman Shares What Went Wrong After Receiving a Mesh Blad...

Donna Miser joins Michelle Llamas on the Drugwatch Podcast to discuss complications she experienced from a transvaginal mesh bladder sling.
drugwatch.com

After Years of Regulation, Toxic Chemicals in Everyday Products Sti...

Even after years of regulation, Americans still face serious health dangers from toxic chemicals in everyday products.
drugwatch.com

Permanent Vision Loss: A Mom of Three’s Unexpected Complication Aft...

A mom of three shares her experience suffering permanent vision loss, called NAION, after taking Ozempic for diabetes and weight loss.
drugwatch.com

FDA Warnings and Reports of ‘Internal Bra’ Complications May Lead t...

Lawyers are investigating internal bra lawsuits after studies and the FDA warn of complications.
drugwatch.com

Beauty’s Dark Side: Toxic Ingredients in Your Cosmetic Products

Drugwatch lists five of the most dangerous chemicals in beauty products, provides expert safety tips and evaluates side effect data.
drugwatch.com

Dexcom G6 Continuous Glucose Monitoring (CGM) Lawsuit

Dexcom G6 lawsuits claim that the CGM is defective, causing inaccurate readings and failing to alert users to dangerous blood glucose levels.
drugwatch.com

Ocaliva Lawsuit (March 2026) Liver Injury Claims

Learn more about Ocaliva liver injury lawsuits, and find out if you qualify to file a lawsuit for potential compensation.
drugwatch.com

FreeStyle Libre Sensor Lawsuit

FreeStyle Libre sensor lawsuits allege that Libre 3 and Libre 3 Plus provide inaccurate glucose readings that lead to injuries. See if you qualify.